Filter By:

CAR T-cell update: therapy improves outcomes for patients with B-cell lymphoma

An international phase-2 trial of a CAR T-cell therapy found that 52 percent of patients responded favorably.

An unexpected success for cancer immunotherapy treating prostate cancer
ASH annual meeting features top advances in blood cancer research—and snow